[HTML][HTML] Erlotinib for elderly patients with non‑small‑cell lung cancer: Subset analysis from a population‑based observational study by the Ibaraki Thoracic Integrative …

K Kurishima, H Satoh, T Kaburagi… - Molecular and …, 2013 - spandidos-publications.com
The incidence and mortality of lung cancer have increased worldwide over the last decades,
with an observed increased incidence particularly among elderly populations. It has not yet …

Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative …

K KURISHIMA, H SATOH… - Molecular & Clinical …, 2013 - search.ebscohost.com
The incidence and mortality of lung cancer have increased worldwide over the last decades,
with an observed increased incidence particularly among elderly populations. It has not yet …

[HTML][HTML] Erlotinib for elderly patients with non‑small‑cell lung cancer: Subset analysis from a population‑based observational study by the Ibaraki Thoracic Integrative …

K Kurishima, H Satoh, T Kaburagi… - Molecular and …, 2013 - spandidos-publications.com
The incidence and mortality of lung cancer have increased worldwide over the last decades,
with an observed increased incidence particularly among elderly populations. It has not yet …

[引用][C] Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative …

K KURISHIMA, H SATOH, T KABURAGI… - Molecular and Clinical …, 2013 - cir.nii.ac.jp
Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a
population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research …

Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative …

K KURISHIMA, H SATOH, T KABURAGI… - Molecular and …, 2013 - search.proquest.com
The incidence and mortality of lung cancer have increased worldwide over the last decades,
with an observed increased incidence particularly among elderly populations. It has not yet …

Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative …

K Kurishima, H Satoh, T Kaburagi… - Molecular and …, 2013 - pubmed.ncbi.nlm.nih.gov
The incidence and mortality of lung cancer have increased worldwide over the last decades,
with an observed increased incidence particularly among elderly populations. It has not yet …

[HTML][HTML] Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative …

K KURISHIMA, H SATOH, T KABURAGI… - … and Clinical Oncology, 2013 - ncbi.nlm.nih.gov
The incidence and mortality of lung cancer have increased worldwide over the last decades,
with an observed increased incidence particularly among elderly populations. It has not yet …

[HTML][HTML] Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative …

K Kurishima, H Satoh, T Kaburagi… - … and Clinical Oncology, 2013 - europepmc.org
The incidence and mortality of lung cancer have increased worldwide over the last decades,
with an observed increased incidence particularly among elderly populations. It has not yet …

Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative …

K Kurishima, H Satoh, T Kaburagi… - … and Clinical Oncology, 2013 - europepmc.org
The incidence and mortality of lung cancer have increased worldwide over the last decades,
with an observed increased incidence particularly among elderly populations. It has not yet …